BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tong S, Kaitu'u-Lino TJ, Hastie R, Brownfoot F, Cluver C, Hannan N. Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia. Am J Obstet Gynecol 2022;226:S1157-70. [PMID: 32946849 DOI: 10.1016/j.ajog.2020.09.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang L, Tang K, Magee LA, von Dadelszen P, Ekeroma A, Li X, Zhang E, Bhutta ZA. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat Rev Endocrinol. [DOI: 10.1038/s41574-022-00734-y] [Reference Citation Analysis]
2 Hussain S, Singh A, Antony B, Klugarová J, Murad MH, Jayraj AS, Langaufová A, Klugar M. Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis. JCM 2022;11:4675. [DOI: 10.3390/jcm11164675] [Reference Citation Analysis]
3 Hastie R, Bergman L, Walker SP, Kaitu'u-Lino T, Hannan NJ, Brownfoot F, Schell S, Harper A, Cannon P, Cluver CA, Tong S. Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia. J Am Heart Assoc 2022;:e024395. [PMID: 35943054 DOI: 10.1161/JAHA.121.024395] [Reference Citation Analysis]
4 Mazurakova A, Koklesova L, Samec M, Kudela E, Sivakova J, Pribulova T, Pec MJ, Pec M, Kello M, Büsselberg D, Golubnitschaja O, Gaspar L, Caprnda M, Adamek M, Prosecky R, Eminova E, Baranenko D, Kruzliak P, Kubatka P, Biringer K. Flavonoids exert potential in the management of hypertensive disorders in pregnancy. Pregnancy Hypertension 2022;29:72-85. [DOI: 10.1016/j.preghy.2022.06.007] [Reference Citation Analysis]
5 Magee LA, Nicolaides KH, von Dadelszen P. Preeclampsia. N Engl J Med 2022;386:1817-32. [PMID: 35544388 DOI: 10.1056/NEJMra2109523] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
6 Muglia L, Tong S, Ozanne S, Benhalima K. Maternal factors during pregnancy influencing maternal, fetal and childhood outcomes: Meet the Guest Editors. BMC Med 2022;20:114. [PMID: 35264147 DOI: 10.1186/s12916-022-02294-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Valias GR, Gomes PRL, Amaral FG, Alnuaimi S, Monteiro D, O'sullivan S, Zangaro R, Cipolla-neto J, Acuna J, Baltatu OC, Campos LA. Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia. Front Mol Biosci 2022;9:800638. [DOI: 10.3389/fmolb.2022.800638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Myatt L. The prediction of preeclampsia: the way forward. Am J Obstet Gynecol 2022;226:S1102-S1107.e8. [PMID: 33785181 DOI: 10.1016/j.ajog.2020.10.047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
9 MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu'u-Lino TJ. Clinical tools and biomarkers to predict preeclampsia. EBioMedicine 2021;75:103780. [PMID: 34954654 DOI: 10.1016/j.ebiom.2021.103780] [Reference Citation Analysis]
10 Costantine MM, West H, Wisner KL, Caritis S, Clark S, Venkataramanan R, Stika CS, Rytting E, Wang X, Ahmed MS; Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric-Fetal Pharmacology Research Centers (OPRC) Network, Bethesda, MD. A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia. Am J Obstet Gynecol 2021;225:666.e1-666.e15. [PMID: 34033812 DOI: 10.1016/j.ajog.2021.05.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
11 Poniedziałek-Czajkowska E, Mierzyński R. Could Vitamin D Be Effective in Prevention of Preeclampsia? Nutrients 2021;13:3854. [PMID: 34836111 DOI: 10.3390/nu13113854] [Reference Citation Analysis]
12 Cluver CA, Hiscock R, Decloedt EH, Hall DR, Schell S, Mol BW, Brownfoot F, Kaitu'u-Lino TJ, Walker SP, Tong S. Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial. BMJ 2021;374:n2103. [PMID: 34551918 DOI: 10.1136/bmj.n2103] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
13 de Alwis N, Beard S, Binder NK, Pritchard N, Kaitu'u-Lino TJ, Walker SP, Stock O, Groom KM, Petersen S, Henry A, Said JM, Seeho S, Kane SC, Tong S, Hannan NJ. LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast. Pregnancy Hypertens 2021;25:255-61. [PMID: 34325289 DOI: 10.1016/j.preghy.2021.07.243] [Reference Citation Analysis]
14 Han C, Chen YY, Dong JF. Prothrombotic state associated with preeclampsia. Curr Opin Hematol 2021;28:323-30. [PMID: 34267080 DOI: 10.1097/MOH.0000000000000678] [Reference Citation Analysis]
15 de Alwis N, Binder NK, Hannan NJ. Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy. Trends Mol Med 2021;27:824-5. [PMID: 34183259 DOI: 10.1016/j.molmed.2021.05.003] [Reference Citation Analysis]
16 Poniedziałek-Czajkowska E, Mierzyński R, Dłuski D, Leszczyńska-Gorzelak B. Prevention of Hypertensive Disorders of Pregnancy-Is There a Place for Metformin? J Clin Med 2021;10:2805. [PMID: 34202343 DOI: 10.3390/jcm10132805] [Reference Citation Analysis]
17 Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet 2021;398:341-54. [PMID: 34051884 DOI: 10.1016/S0140-6736(20)32335-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]